Comparison of Two Methods of Bronchial Methacholine Provocation
NCT00503659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2011-10-12
Summary
This study is meant to compare two routine diagnostic approaches in patients with bronchial asthma. Patients are challenged with methacholine in order to measure their bronchial response. We compare the evaluation of the effects of incremental concentrations versus incremental dosages.
Conditions
- Bronchial Hyperreactivity
- Bronchial Asthma
Interventions
- PROCEDURE
-
Bronchial methacholine provocation
A short five-breath dosimeter protocol using a five-step dilution schedule according to ATS guidelines (0.0625, 0.25, 1, 4, 16 mg/ml methacholine)
- PROCEDURE
-
Bronchial methacholine provocation
A five-step protocol using a single dilution of 16 mg/ml methacholine (0.01, 0.1, 0.4, 0.8, 1.6 mg)
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Stefan Zielen, M.D., Ph.D. · Goethe University, Department of Pulmonology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Investigation to Identify Predictors of Response to a Treatment With Montelukast
NCT00721240 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT05634473 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics
NCT00857857 ·Status: COMPLETED ·Phase: PHASE2
-
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 ·Status: RECRUITING ·Phase: NA
-
Methacholine Challenge: Comparison of Doubling and Quadrupling Methacholine Dose Regimes Using the Tidal Volume Method
NCT00890539 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
NCT00557141 ·Status: UNKNOWN
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vilanterol on Methacholine Challenge Results
NCT03315000 ·Status: COMPLETED ·Phase: PHASE4
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children
NCT01144910 ·Status: WITHDRAWN
-
The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma
NCT05603494 ·Status: UNKNOWN ·Phase: NA
-
A Study on the Diagnostic Value of the Methacholine Choline Provocation Test in the Asthmatic Population
NCT05870436 ·Status: UNKNOWN
-
Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough
NCT00916526 ·Status: COMPLETED ·Phase: NA
-
A Study of MK0359 in Patients With Chronic Asthma (0359-013)
NCT00482898 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Fluticasone Furoate on Methacholine Challenge
NCT03898466 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA)
NCT01170429 ·Status: UNKNOWN ·Phase: PHASE4
-
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991 ·Status: COMPLETED
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Adequacy of Management of Patients With Asthma Exacerbation in Martinique
NCT05253391 ·Status: UNKNOWN
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma
NCT02124226 ·Status: UNKNOWN ·Phase: PHASE3